VRNM: Summary for Verenium Corporation - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 4:53am EST - Canadian Markets open in 4 hours and 37 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Verenium Corporation (VRNM)

On Feb 9: 4.71 USD 0.00 (0.00%)

MORE ON VRNM

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Verenium Corporation (NGM:VRNM) Delayed quote data

Last Trade:	4.71 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	4.71
Open:	N/A
Bid:	N/A
Ask:	8.06 x 100
1y Target Est:	11.67

Day's Range:	N/A - N/A
52wk Range:	2.76 - 16.80
Volume:	0
Avg Vol (3m):	152,087
Market Cap:	55.18M
P/E (ttm):	N/A
EPS (ttm):	-5.69
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add VRNM to Portfolio

Download Data

HEADLINES

•	Somaxon, Borders: Midday Volume Plays
	at TheStreet.com (Wed, Feb 3)

•	Verenium and BP Extend Galaxy Joint Development Program
	PRNewswire (Mon, Feb 1)

•	VERENIUM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
	EDGAR Online (Mon, Feb 1)

•	Another Ethanol Player Back From the Dead
	Indie Research (Thu, Jan 7)

•	Beware of These Strong Buys
	at Motley Fool (Thu, Dec 31)

•	[$$] Shell, Other Oil Firms Bolster Biofuels Spending
	at The Wall Street Journal Online (Tue, Dec 29)

•	[$$] Cellulosic-Ethanol Mandate Faces Snags
	at The Wall Street Journal Online (Sun, Dec 27)

•	Ethanol Stocks Advance as Energy Giant Ups Exposure
	Indie Research (Tue, Dec 15)

•	VERENIUM CORP Financials
	EDGAR Online Financials (Fri, Nov 13)

•	VERENIUM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
	EDGAR Online (Mon, Nov 9)

More Headlines for VRNM...

ANALYST

EPS Est (next year) (Dec-09) :	-5.80
EPS Est (in 2 years) (Dec-10) :	-3.90
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Verenium Corporation engages in the development and production of specialty enzyme products, and production and commercialization of biofuels. It operates in two segments, Biofuels and Specialty Enzymes.

Full Company Profile

Add to Portfolio

Email to a Friend

•